Patterns of anti‐CGRP mAbs use and variation of triptan consumption following treatment initiation: A descriptive drug utilization study in the Tuscany region, Italy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patterns of anti‐CGRP mAbs use and variation of triptan consumption following treatment initiation: A descriptive drug utilization study in the Tuscany region, Italy
Authors
Keywords
-
Journal
HEADACHE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-13
DOI
10.1111/head.14639
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany
- (2023) Giulia Hyeraci et al. HEADACHE
- Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study
- (2023) Luigi Francesco Iannone et al. CEPHALALGIA
- Microwave oscillator on a chip
- (2023) Oliver Graydon Nature Photonics
- Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS score
- (2022) Luigi Francesco Iannone et al. CNS DRUGS
- Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice
- (2022) Francesco De Logu et al. Nature Communications
- A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States
- (2022) Lynda J. Krasenbaum et al. JOURNAL OF HEADACHE AND PAIN
- Calcitonin gene-related peptide-targeting drugs for migraine: how pharmacology might inform treatment decisions
- (2022) Linda Al-Hassany et al. LANCET NEUROLOGY
- Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claims Study
- (2022) Oralee J Varnado et al. Patient Preference and Adherence
- European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
- (2022) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- The ultimate guide to the anti-CGRP monoclonal antibodies galaxy
- (2022) Davide Mascarella et al. NEUROLOGICAL SCIENCES
- Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy : The multicenter prospective cohort GARLIT study
- (2022) Fabrizio Vernieri et al. EUROPEAN JOURNAL OF NEUROLOGY
- Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study
- (2022) Andrea Spini et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Fremanezumab for the Preventive Treatment of Migraine: Subgroup Analysis by Number of Prior Preventive Treatments with Inadequate Response
- (2021) Ladislav Pazdera et al. CEPHALALGIA
- Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study
- (2021) Stewart J. Tepper et al. JOURNAL OF HEADACHE AND PAIN
- Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study
- (2021) Piero Barbanti et al. HEADACHE
- Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache
- (2021) Umberto Pensato et al. NEUROLOGICAL SCIENCES
- Migraine Characteristics, Comorbidities, Healthcare Resource Utilization, and Associated Costs of Early Users of Erenumab in the USA: A Retrospective Cohort Study Using Administrative Claims Data
- (2021) David Chandler et al. Pain and Therapy
- Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study
- (2021) Bianca Raffaelli et al. CEPHALALGIA
- From Inception to ConcePTION: Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding
- (2021) Nicolas H. Thurin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Real‐world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real‐world study
- (2021) Jonathan Gladstone et al. HEADACHE
- Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study
- (2021) Fabrizio Vernieri et al. JOURNAL OF HEADACHE AND PAIN
- Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
- (2020) Raffaele Ornello et al. JOURNAL OF HEADACHE AND PAIN
- Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans
- (2020) Tessa de Vries et al. PHARMACOLOGY & THERAPEUTICS
- Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study
- (2020) Piero Barbanti et al. HEADACHE
- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
- (2019) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas
- (2019) Giuseppe Roberto et al. BMC Endocrine Disorders
- Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats
- (2019) Kirk W Johnson et al. CEPHALALGIA
- The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?
- (2018) Gianluca Trifirò et al. DRUG SAFETY
- Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort Study with the pharmacy database IADB.nl: The PharmLines Initiative
- (2018) Rahmat Sediq et al. Clinical Epidemiology
- Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Lars Jacob Stovner et al. LANCET NEUROLOGY
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment
- (2015) Lars Edvinsson BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
- (2014) F. A. Russell et al. PHYSIOLOGICAL REVIEWS
- Seizure diaries for clinical research and practice: Limitations and future prospects
- (2012) Robert S. Fisher et al. EPILEPSY & BEHAVIOR
- Italian guidelines for primary headaches: 2012 revised version
- (2012) Paola Sarchielli et al. JOURNAL OF HEADACHE AND PAIN
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started